Article Information
History
- December 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sulaimon Akanmu1,*,
- Bobby Brooke Herrera2,3,4,5,*,
- Beth Chaplin2,
- Sade Ogunsola1,
- Akin Osibogun1,6,
- Fatima Onawoga1,
- Sarah John-Olabode1,
- Iorhen E. Akase1,
- Augustina Nwosu1,
- Donald J Hamel2,
- Charlotte A Chang2 and
- Phyllis J Kanki2,†
- 1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
- 2Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- 3Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
- 4Rutgers Global Health Institute, Rutgers University, New Brunswick, NJ, USA
- 5Mir Biosciences, Inc., Boston, MA, USA
- 6Lagos State COVID-19 Taskforce, Lagos State Ministry of Health, Lagos, Nigeria
- ↵†Correspondence: PK, pkanki{at}hsph.harvard.edu